Neurogene (NGNE) Other Accumulated Expenses (2013 - 2022)

Neurogene (NGNE) has 7 years of Other Accumulated Expenses data on file, last reported at $1.2 million in Q4 2022.

• Quarterly Other Accumulated Expenses fell 4.65% year-over-year to $1.2 million in Q4 2022, while the trailing twelve-month figure through Dec 2022 was $1.2 million (down 4.65% YoY) and the FY2022 annual result came in at $1.2 million, down 4.65% from the prior year.
• Other Accumulated Expenses slipped to $1.2 million in Q4 2022, from $1.2 million in the prior quarter.
• In the past five years, Other Accumulated Expenses ranged from a high of $1.2 million in Q4 2021 to a low of $240000.0 in Q4 2018.
• A 5-year average of $780600.0 and a median of $927000.0 in 2020 frame the typical range for Other Accumulated Expenses.
• Annual changes were most pronounced in 2020 — Other Accumulated Expenses jumped 173.45% — and 2022, when it fell 4.65%.
• Tracing NGNE's Other Accumulated Expenses over 5 years: stood at $240000.0 in 2018, then surged by 41.25% to $339000.0 in 2019, then jumped by 173.45% to $927000.0 in 2020, then jumped by 32.36% to $1.2 million in 2021, then fell by 4.65% to $1.2 million in 2022.
• The last three Other Accumulated Expenses figures came in at $1.2 million (Q4 2022), $1.2 million (Q4 2021), and $927000.0 (Q4 2020), per Business Quant data.